BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35006295)

  • 1. The relationship between the severity of oral dryness and the use of dry-mouth interventions by various subgroups of dry-mouth patients.
    Assy Z; Brand HS; Bots CP; Bikker FJ
    Clin Oral Investig; 2022 Mar; 26(3):3097-3108. PubMed ID: 35006295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between oral dryness and use of dry-mouth interventions in Sjögren's syndrome patients.
    Assy Z; Bikker FJ; Picauly O; Brand HS
    Clin Oral Investig; 2022 Feb; 26(2):1465-1475. PubMed ID: 34374853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in perceived intra-oral dryness in various dry-mouth patients as determined using the Regional Oral Dryness Inventory.
    Assy Z; Bots CP; Arisoy HZ; Gülveren SS; Bikker FJ; Brand HS
    Clin Oral Investig; 2021 Jun; 25(6):4031-4043. PubMed ID: 33496869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and efficacy of dry-mouth interventions in Sjögren's disease patients and possible association with perceived oral dryness and patients' discomfort.
    Assy Z; van Santen JS; Brand HS; Bikker FJ
    Clin Oral Investig; 2023 Sep; 27(9):5529-5537. PubMed ID: 37507599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences in perceived oral dryness as determined with a newly developed questionnaire, the Regional Oral Dryness Inventory.
    Assy Z; Jager DHJ; Mashhour E; Bikker FJ; Brand HS
    Clin Oral Investig; 2020 Nov; 24(11):4051-4060. PubMed ID: 32382921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral health status, related behaviours and perceived stress in xerostomia, Sicca and Sjögren's syndromes patients - a cross-sectional study.
    Stankeviciene I; Stangvaltaite-Mouhat L; Aleksejuniene J; Mieliauskaite D; Talijuniene I; Butrimiene I; Bendinskaite R; Puriene A
    BMC Oral Health; 2024 Apr; 24(1):454. PubMed ID: 38622697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren's syndrome.
    Du H; Fu Z; Zhong Y; Yuan Y; Zhao J; Ding X; Li S; Gao S; Zhu Y; Song H; Wu H
    Front Immunol; 2022; 13():1039599. PubMed ID: 36439107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
    Erlichman M
    Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
    Wu AJ
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry Mouth and Clinical Oral Dryness Scoring Systems.
    Das P; Challacombe SJ
    Prim Dent J; 2016 Feb; 5(1):77-79. PubMed ID: 29029657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient satisfaction and impact of salivary flow rate on effectiveness of xerostomia products.
    Purdie MJ; Carpenter MD; Noll JL; Stephens CL; Taylor YJ; Hammitt KM; Napenas JJ; Brennan MT
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):236-241. PubMed ID: 36266177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.
    Karagozoglu KH; Vissink A; Forouzanfar T; de Visscher JGAM; Maarse F; Brand HS; van de Ven PM; Jager DHJ
    Rheumatology (Oxford); 2021 Mar; 60(3):1353-1363. PubMed ID: 32949144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.
    van der Reijden WA; Vissink A; Veerman EC; Amerongen AV
    Ann Rheum Dis; 1999 Aug; 58(8):465-74. PubMed ID: 10419864
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term effectiveness of a novel intra-oral electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham-controlled feasibility study (LEONIDAS-1).
    Fedele S; Al-Hamad A; Mercadante V; Porter S; Isenberg D; Poveda-Gallego A; Brown ST
    J Oral Pathol Med; 2023 Aug; 52(7):619-627. PubMed ID: 37220073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrostimulation for the treatment of a dry mouth feeling].
    Janssen MJ; Bots CP; Brand HS
    Ned Tijdschr Tandheelkd; 2015 Oct; 122(10):517-20. PubMed ID: 26465014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.
    Aliko A; Alushi A; Tafaj A; Isufi R
    Rheumatol Int; 2012 Sep; 32(9):2877-81. PubMed ID: 21898068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the management of dry mouth: topical therapies.
    Furness S; Worthington HV; Bryan G; Birchenough S; McMillan R
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008934. PubMed ID: 22161442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral involvement in patients with primary Sjögren's syndrome. Multidisciplinary care by dentists and rheumatologists.
    López-Pintor RM; Fernández Castro M; Hernández G
    Reumatol Clin; 2015; 11(6):387-94. PubMed ID: 26022574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.